Jeffrey Eisele
Corporate Officer/Principal chez APELLIS PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Jeffrey Eisele is currently the Chief Development Officer at Apellis Pharmaceuticals, Inc. Prior to this, he worked at Novartis, Inc. as the VP-Global Biostatistics & Head-Neuroscience.
He completed his undergraduate degree at George Washington University and his graduate and doctorate degrees at the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/01/2024 | 57 208 ( 0,05% ) | 3 M $ | 30/04/2024 |
Postes actifs de Jeffrey Eisele
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Jeffrey Eisele
| Sociétés | Poste | Fin |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
Formation de Jeffrey Eisele
| George Washington University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
